Search research articles
Contact Us
Filters
Showing results (251-260 of 279) with videos related to
Page
of 28
Sort By:
Molecular Imaging and Biology
|
October 5, 2014
Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis
Oluwaseun A Odewole, Oyeladun A Oyenuga, Funmilayo Tade, et al.
Practical Radiation Oncology
|
July 20, 2024
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
Brachytherapy
|
August 21, 2021
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer
Vishal R Dhere, Benjamin W Fischer-Valuck, Subir Goyal, et al.
Practical Radiation Oncology
|
July 30, 2025
Volumetric Changes and Acute Toxicity with <sup>68</sup>Ga Prostate-Specific Membrane Antigen vs <sup>18</sup>F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
The Journal of Urology
|
October 23, 2013
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial
David M Schuster, Peter T Nieh, Ashesh B Jani, et al.
Radiology
|
June 30, 2026
<sup>18</sup>F-Fluciclovine or <sup>68</sup>Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial
Olayinka A Abiodun-Ojo, Ashesh B Jani, Subir Goyal, et al.
European Journal of Radiology
|
April 25, 2018
Prospective evaluation of fluciclovine (<sup>18</sup>F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients
Oladunni Akin-Akintayo, Funmilayo Tade, Pardeep Mittal, et al.
Clinical Genitourinary Cancer
|
April 26, 2026
Utilization, Cost, and Subsequent Salvage Treatment of Ablative Therapies for Localized Prostate Cancer in the United States
Nikhil T Sebastian, Dattatraya Patil, Pretesh R Patel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 20, 2016
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT
Oluwaseun A Odewole, Funmilayo I Tade, Peter T Nieh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2021
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on <sup>18</sup>F-Fluciclovine PET/CT Guidance
Olayinka A Abiodun-Ojo, Ashesh B Jani, Akinyemi A Akintayo, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 279) with videos related to
Sort By:
Page
of 28
Molecular Imaging and Biology
|
October 5, 2014
Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis
Oluwaseun A Odewole, Oyeladun A Oyenuga, Funmilayo Tade, et al.
Practical Radiation Oncology
|
July 20, 2024
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
Brachytherapy
|
August 21, 2021
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer
Vishal R Dhere, Benjamin W Fischer-Valuck, Subir Goyal, et al.
Practical Radiation Oncology
|
July 30, 2025
Volumetric Changes and Acute Toxicity with <sup>68</sup>Ga Prostate-Specific Membrane Antigen vs <sup>18</sup>F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
The Journal of Urology
|
October 23, 2013
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial
David M Schuster, Peter T Nieh, Ashesh B Jani, et al.
Radiology
|
June 30, 2026
<sup>18</sup>F-Fluciclovine or <sup>68</sup>Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial
Olayinka A Abiodun-Ojo, Ashesh B Jani, Subir Goyal, et al.
European Journal of Radiology
|
April 25, 2018
Prospective evaluation of fluciclovine (<sup>18</sup>F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients
Oladunni Akin-Akintayo, Funmilayo Tade, Pardeep Mittal, et al.
Clinical Genitourinary Cancer
|
April 26, 2026
Utilization, Cost, and Subsequent Salvage Treatment of Ablative Therapies for Localized Prostate Cancer in the United States
Nikhil T Sebastian, Dattatraya Patil, Pretesh R Patel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 20, 2016
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT
Oluwaseun A Odewole, Funmilayo I Tade, Peter T Nieh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2021
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on <sup>18</sup>F-Fluciclovine PET/CT Guidance
Olayinka A Abiodun-Ojo, Ashesh B Jani, Akinyemi A Akintayo, et al.
Page
of 28